ReviewPediatric nephrology (Berlin, Germany)2026
Adequacy of dialysis in children and adolescents: more than just Kt/V.
Review in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The concept of dialysis adequacy has evolved over time. Initially, the focus of dialysis adequacy was on the clearance of small molecules, namely urea. However, limitations of urea-based adequacy assessment and the importance of other elements have become increasingly recognized. There is growing evidence that removal of middle molecules is associated with improved clinical outcomes. Besides clearance of solutes, several clinical markers serve as measures of adequate dialysis. Phosphorus control can have many clinical benefits, but although phosphorus is a small molecule, the kinetics of phosphorus removal by dialysis are different than that of urea. Cardiovascular comorbidities and outcomes are heavily influenced by appropriate volume control, avoiding both excess fluid overload and volume depletion. Growth is an important outcome that does not correlate with urea clearance but may be better achieved using an intensified dialysis schedule and/or a modality that promotes removal of middle molecules. Rather than focusing solely on factors identified by the medical community, adequate dialysis should also address factors identified by patients and their families, including intradialytic and interdialytic symptoms, life participation, and quality of life. There is a bidirectional relationship between dialysis adequacy and both residual kidney function and dialysis access. Rather than applying a standard fixed prescription to all patients, there should be greater emphasis on personalizing the dialysis prescription using shared decision-making with the patient and family.
Indexed as
Identifiers
42717002What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.